📅27 Apr 2pm Preparing for Disease Modifying Therapies for Dementia: implications for research, trials & clinical services UCL Queen Square Institute of Neurology 🟧 Hilary Evans-Newton 🟧 Kate Lee Jonathan Schott Prof Cath Mummery Gill Livingston @RabLab_UCSF Jonathan Graff-Radford great programme & speakers dementiaresearcher.nihr.ac.uk/event/preparin…

There’s still time to register for The Basics of Biofluid Based Biomarkers PIA on April 7! Join for a look into the basics of core blood biomarkers and analytics, featuring panel moderator Charlotte Teunissen with panelists Ulf Andreasson, Ph.D. & Inge Verberk. Register: bit.ly/3MaT6Xp

Don’t miss The Basics of Biofluid Based Biomarkers PIA: Core CSF Biomarkers and Analytics on April 25. Hear a presentation of content from moderator Charlotte Teunissen and panelists Alicia Algeciras-Schimnich, Ph.D. & Markus Otto, M.D., with a quiz and Q&A. Register: bit.ly/41B3EUj

Alzheimer's Association #pTau round Robin study ⬇️⬇️⬇️ Jonathan Schott Ashvini Keshavan

A world-class research team UCLH and UCL Queen Square Institute of Neurology led by Jonathan Schott & Ashvini Keshavan has been awarded £3.76m to carry out a nationwide trial to identify accurate and quick blood tests that can diagnose dementia. uclhospitals.brc.nihr.ac.uk/news/blood-tes… Alzheimer's Society Alzheimer's Research UK National Institute for Health and Care Research

Honoured to be co-leading the ADAPT study of plasma p-tau217 in the UK with Jonathan Schott, bringing together expertise from UCL in dementia research DRC@UCL, nationally accredited lab UCLH, patient&public engagement University of Kent, cost-effectiveness LSE

Indian-origin neurologist Ashvini Keshavan's UK study to revolutionise dementia diagnosis #Neurology #dementia #Alzheimers #healthcare newsdrum.in/international/…

Thanks Asian Voice for the coverage of the role that the Blood Biomarker challenge grant award will play in bringing accurate dementia diagnosis to local communities in the UK, and for featuring the ADAPT study. asian-voice.com/News/UK/HOPE-F… Research at ARUK Alzheimer's Society

Academic clinical lecturer post ⁦in #Neurology ⁦Imperial Department of Brain Sciences⁩ with a focus on #Dementia & opportunities to work with colleagues across ⁦Imperial College London⁩ and 2 ⁦UK Dementia Research Institute⁩ Centres. Please RT and do get in touch if interested! oriel.nhs.uk/Web/Vacancy/Va…

Thanks for the interview; privileged to lead the ADAPT study with Jonathan Schott UCL - buzzing from our first in person steering group meeting with protocol drafting, patient/public engagement, staff recruitment and collaboration with Imperial College London LSE University of Kent all underway!

Do apply to work with this great team on the innovative DIADEM study looking at both digital auditory and blood biomarkers in real world memory clinics, headed by Charles Marshall & Chris Hardy at UCL.

Looking forward to this opportunity to discuss blood tests for Alzheimer’s, answer questions from the public, and speak about the ADAPT study - all welcome, register to join at 13:00 UK time today!

Post-Doctoral Research Fellow to work at the MRC Prion Unit at UCL on multiplexed seed amplification assays in mixed dementia, and improving sensitivity. Please take a look and email me if you have any questions or would like to look around the labs. ucl.ac.uk/work-at-ucl/se…

The collection of #blood #biomarkers studies using NULISA as presented at day two of #AAIC2024 is now available as a pre-print 🩸🧪🧠 medrxiv.org/content/10.110… Andrea L. Benedet Marc Suárez-Calvet 🧠🧪 🩺🌈 @Alamarbio Jonathan Schott Barbara Alessandro Padovani Göteborgs universitet / University of Gothenburg Barcelonaβeta Brain Research Center

Great experience to facilitate and author this paper with Nicholas Ashton Wagner S. Brum Jonathan Schott Henrik Zetterberg - unprecedented level of industry and academic collaboration showing p-tau217 has highest fold change in symptomatic AD over non-AD participants from DRC@UCL